These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 18190295)

  • 1. Cost-effectiveness of HIV testing and treatment in the United States.
    Walensky RP; Freedberg KA; Weinstein MC; Paltiel AD
    Clin Infect Dis; 2007 Dec; 45 Suppl 4(Suppl 4):S248-54. PubMed ID: 18190295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cost-effectiveness of voluntary counseling and testing of hospital inpatients for HIV infection.
    Lurie P; Avins AL; Phillips KA; Kahn JG; Lowe RA; Ciccarone D
    JAMA; 1994 Dec; 272(23):1832-8. PubMed ID: 7990217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Costs and consequences of the US Centers for Disease Control and Prevention's recommendations for opt-out HIV testing.
    Holtgrave DR
    PLoS Med; 2007 Jun; 4(6):e194. PubMed ID: 17564488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cost-effectiveness of HIV testing of physicians and dentists in the United States.
    Phillips KA; Lowe RA; Kahn JG; Lurie P; Avins AL; Ciccarone D
    JAMA; 1994 Mar; 271(11):851-8. PubMed ID: 8114240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The president's fiscal year 2007 initiative for human immunodeficiency virus counseling and testing expansion in the United States: a scenario analysis of its coverage, impact, and cost-effectiveness.
    Holtgrave DR
    J Public Health Manag Pract; 2007; 13(3):239-43. PubMed ID: 17435490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expanded screening for HIV in the United States--an analysis of cost-effectiveness.
    Paltiel AD; Weinstein MC; Kimmel AD; Seage GR; Losina E; Zhang H; Freedberg KA; Walensky RP
    N Engl J Med; 2005 Feb; 352(6):586-95. PubMed ID: 15703423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Who should be screened for HIV infection? A cost-effectiveness analysis.
    McCarthy BD; Wong JB; Muñoz A; Sonnenberg FA
    Arch Intern Med; 1993 May; 153(9):1107-16. PubMed ID: 8481077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost-effectiveness of expanded HIV counselling and testing in primary care settings: a first look.
    Phillips KA; Fernyak S
    AIDS; 2000 Sep; 14(14):2159-69. PubMed ID: 11061658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of HIV counseling and testing in US prisons.
    Varghese B; Peterman TA
    J Urban Health; 2001 Jun; 78(2):304-12. PubMed ID: 11419583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insurance coverage and access to HIV testing and treatment: considerations for individuals at risk for infection and for those with undiagnosed infection.
    Kates J; Levi J
    Clin Infect Dis; 2007 Dec; 45 Suppl 4():S255-60. PubMed ID: 18190296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cost-effectiveness of expanded testing for primary HIV infection.
    Coco A
    Ann Fam Med; 2005; 3(5):391-9. PubMed ID: 16189054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventing perinatal transmission of HIV--costs and effectiveness of a recommended intervention.
    Gorsky RD; Farnham PG; Straus WL; Caldwell B; Holtgrave DR; Simonds RJ; Rogers MF; Guinan ME
    Public Health Rep; 1996; 111(4):335-41. PubMed ID: 8711101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of voluntary HIV-1 counselling and testing in reducing sexual transmission of HIV-1 in Kenya and Tanzania.
    Sweat M; Gregorich S; Sangiwa G; Furlonge C; Balmer D; Kamenga C; Grinstead O; Coates T
    Lancet; 2000 Jul; 356(9224):113-21. PubMed ID: 10963247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV.
    Pinkerton SD; Holtgrave DR; Pinkerton HJ
    Arch Intern Med; 1997 Sep; 157(17):1972-80. PubMed ID: 9308509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Funding and implementing routine testing for HIV.
    Munar DE
    Clin Infect Dis; 2007 Dec; 45 Suppl 4():S244-7. PubMed ID: 18190294
    [No Abstract]   [Full Text] [Related]  

  • 16. Evidence-based efforts to prevent HIV infection: an overview of current status and future challenges.
    Holtgrave D
    Clin Infect Dis; 2007 Dec; 45 Suppl 4():S293-9. PubMed ID: 18190302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of interventions to reduce vertical HIV transmission from pregnant women who have not received prenatal care.
    Mrus JM; Tsevat J
    Med Decis Making; 2004; 24(1):30-9. PubMed ID: 15005952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changing epidemiology of HIV/AIDS in the United States: implications for enhancing and promoting HIV testing strategies.
    Fenton KA
    Clin Infect Dis; 2007 Dec; 45 Suppl 4():S213-20. PubMed ID: 18190289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current CDC efforts to prevent and control human immunodeficiency virus infection and AIDS in the United States through information and education.
    Mason JO; Noble GR; Lindsey BK; Kolbe LJ; Van Ness P; Bowen GS; Drotman DP; Rosenberg ML
    Public Health Rep; 1988; 103(3):255-60. PubMed ID: 2836879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interpreting and implementing the 2006 CDC recommendations for HIV testing in health-care settings.
    Lyons MS; Lindsell CJ; Fichtenbaum CJ; Camargo CA
    Public Health Rep; 2007; 122(5):579-83. PubMed ID: 17877304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.